Arcturus Pharmaceutical Corporation

Maureen H McAloon

Richard J Sharpe

Stephen J Galli

Kenneth A Arndt

A method for the topical or systemic treatment of disorders mediated by proteases which result in skin or mucosal lesions, and in particular, pemphigus, cicatricial pemphigoid, bullous pemphigoid, lichen planus, and canker sores, is disclosed wherein the host is treated with an effective amount of N-acetyl ysteine or a derivative thereof, or its pharmaceutically acceptable salt, optionally in a pharmaceutically acceptable diluent or carrier for systemic or topical delivery.

Growing community of inventors

Boston, MA, United States of America

Maureen H McAloon